Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Palvella Therapeutics
company
About
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $45M
- Industries
- Biotechnology,Health Care,Life Science,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Palvella Therapeutics is a start-up life sciences company that focuses on relentlessly and selflessly serving abandoned patient populations with therapies. The company specializes in developing therapies that specifically target the root cause of the disease.Palvella Therapeutics was founded in 2015 and headquartered in Wayne, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
Palvella Therapeutics has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
May 28, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 28, 2020 | Series C | $45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Palvella Therapeutics is funded by 1 investors.
Opaleye Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
